LRIG3 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 8.126200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
9.346000E-01
Normal-vs-Stage2
8.567600E-01
Normal-vs-Stage3
4.594800E-01
Normal-vs-Stage4
9.807600E-01
Stage1-vs-Stage2
6.611600E-01
Stage1-vs-Stage3
2.379400E-01
Stage1-vs-Stage4
9.294000E-01
Stage2-vs-Stage3
2.630200E-01
Stage2-vs-Stage4
7.987800E-01
Stage3-vs-Stage4
1.010600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
8.184000E-01
Normal-vs-AfricanAmerican
9.966800E-01
Normal-vs-Asian
8.331600E-01
Caucasian-vs-AfricanAmerican
4.636400E-01
Caucasian-vs-Asian
9.323200E-01
AfricanAmerican-vs-Asian
6.428200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
8.881800E-01
Normal-vs-Female
7.033000E-01
Male-vs-Female
4.537000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
8.326600E-01
Normal-vs-Age(41-60Yrs)
9.538000E-01
Normal-vs-Age(61-80Yrs)
7.427600E-01
Normal-vs-Age(81-100Yrs)
9.353200E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
7.188400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.831600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
8.007000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.936200E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
9.198600E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
6.521000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
8.090200E-01
Normal-vs-Daily Drinker
5.818800E-01
Normal-vs-Weekly Drinker
8.134000E-01
Normal-vs-Occasional Drinker
9.562000E-01
Normal-vs-Social Drinker
9.077800E-01
Non Drinker-vs-Daily Drinker
4.440500E-02
Non Drinker-vs-Weekly Drinker
9.201200E-01
Non Drinker-vs-Occasional Drinker
5.219600E-01
Non Drinker-vs-Social Drinker
8.296600E-01
Daily Drinker-vs-Weekly Drinker
2.200200E-01
Daily Drinker-vs-Occasional Drinker
2.099600E-02
Daily Drinker-vs-Social Drinker
9.145500E-02
Weekly Drinker-vs-Occasional Drinker
5.573000E-01
Weekly Drinker-vs-Social Drinker
8.023400E-01
Occasional Drinker-vs-Social Drinker
7.339800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
9.927900E-02
Normal-vs-Grade 2
3.653500E-02
Normal-vs-Grade 3
3.912400E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.790780E-01
Grade 1-vs-Grade 3
3.714100E-02
Grade 1-vs-Grade 4
9.927900E-02
Grade 2-vs-Grade 3
1.656570E-01
Grade 2-vs-Grade 4
3.653500E-02
Grade 3-vs-Grade 4
3.912400E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
5.648600E-01
Normal-vs-NonDiabetic
8.328200E-01
Diabetic-vs-NonDiabetic
1.835240E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
7.193800E-01
Normal-vs-NoPancreatitis
7.613200E-01
Pancreatitis-vs-NoPancreatitis
4.498800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
6.794800E-01
Normal-vs-N1
8.775000E-01
N0-vs-N1
3.836400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
8.183000E-01
Normal-vs-TP53-NonMutant
7.610000E-01
TP53-Mutant-vs-TP53-NonMutant
7.185600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
